Veru logo

Veru Share Price (NASDAQ: VERU)

$3.63

0.04

(1.11%)

Live

Last updated on

Check the interactive Veru Stock chart to analyse performance

Veru stock performance

as on August 18, 2025 at 11:45 PM IST

  • Today's Low:$3.59
    Today's High:$3.63

    Day's Volatility :1.1%

  • 52 Weeks Low:$2.64
    52 Weeks High:$14.20

    52 Weeks Volatility :81.41%

Veru Stock Returns

PeriodVeru IncSector (Consumer Staples)Index (Russel 2000)
3 Months
-30.95%
-0.1%
0.0%
6 Months
-34.83%
1.4%
0.0%
1 Year
-57.21%
1.9%
0.0%
3 Years
-97.95%
6.3%
-11.6%

Veru Inc Key Stats

Check Veru key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.59
Open
$3.64
Today's High
$3.83
Today's Low
$3.58
Market Capitalization
$52.6M
Today's Volume
$216.5K
52 Week High
$14.2
52 Week Low
$2.64
Revenue TTM
$16.9M
EBITDA
$-38.2M
Earnings Per Share (EPS)
$6.0
PE Ratio
0.6
Profit Margin
-193.71%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-106.02%

Stock Returns calculator for Veru Stock including INR - Dollar returns

The Veru stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Veru investment value today

Current value as on today

₹47,339

Returns

₹52,661

(-52.66%)

Returns from Veru Stock

₹56,734 (-56.73%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Veru Stock

98.41%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Investment in Veru Shares from India has grown by 98.41% over the past 30 days, indicating increased transactional activity.

21%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Veru Stock from India on INDmoney has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Veru Inc

  • Name

    Holdings %

  • BlackRock Inc

    5.90%

  • MPM Oncology Impact Management LP

    4.50%

  • Vanguard Group Inc

    4.37%

  • Geode Capital Management, LLC

    2.07%

  • State Street Corp

    1.52%

  • UBS Group AG

    1.34%

Analyst Recommendation on Veru Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Veru(by analysts ranked 0 to 5 stars)

Veru Share Price Target

What analysts predicted

Upside of 588.71%

Target:

$25.00

Current:

$3.63

Veru share price target is $25.00, a slight Upside of 588.71% compared to current price of $3.63 as per analysts' prediction.

Veru Stock Insights

  • Price Movement

    In the last 1 month, VERU stock has moved down by -39.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 3.95M → 6.65M (in $), with an average increase of 40.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -8.94M → -7.33M (in $), with an average increase of 10.5% per quarter
  • VERU vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 124.1%
  • VERU vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 199.0%
  • Price to Sales

    ForVERU every $1 of sales, investors are willing to pay $3.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.

Veru Technicals Summary

Sell

Neutral

Buy

Veru is currently in a neutral trading position according to technical analysis indicators.

Veru Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Veru Inc logo
-38.1%
-34.83%
-57.21%
-97.95%
-87.13%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

About Veru Inc

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Organization
Veru
Employees
210
CEO
Dr. Mitchell S. Steiner F.A.C.S., M.D.
Industry
Consumer Non-Durables

Key Management of Veru Inc

NameTitle
Dr. Mitchell S. Steiner F.A.C.S., M.D.
Chairman, President & CEO
Dr. Harry D. Fisch F.A.C.S., M.D.
Vice Chairman & Chief Corporate Officer
Dr. K. Gary Barnette Ph.D.
Chief Scientific Officer
Mr. Samuel Fisch
Executive Director of Investor Relations & Corporate Communications
Mr. Michael J. Purvis J.D.
Executive VP, General Counsel & Corporate Strategy and Secretary
Mr. Martin Tayler
Executive Vice President of FC2 Global Operations
Mr. Philip R. Greenberg J.D.
Executive VP & Deputy General Counsel
Dr. Domingo Rodriguez M.D.
Executive Vice President of Global Clinical Operations
Dr. Gary Bird Ph.D.
Executive Vice President of Quality & Regulatory Affairs
Alistair Rawson L.L.B., M.B.A.
Executive Vice President of Operations - GPS Sales

Important FAQs about investing in VERU Stock from India :

What is Veru share price today?

Veru share price today is $3.63 as on . Veru share today touched a day high of $3.63 and a low of $3.59.

What is the 52 week high and 52 week low for Veru share?

Veru share touched a 52 week high of $14.20 and a 52 week low of $2.64. Veru stock price today, is trending at $3.63, lower by 74.44% versus the 52 week high.

How to invest in Veru Stock (VERU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Veru on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veru Shares that will get you 0.4132 shares as per Veru share price of $3.63 per share as on August 18, 2025 at 11:45 PM IST.

What is the minimum amount required to buy Veru Stock (VERU) from India?

Indian investors can start investing in Veru (VERU) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Veru stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Veru share’s latest price of $3.63 as on August 18, 2025 at 11:45 PM IST, you will get 2.7548 shares of Veru. Learn more about fractional shares .

What are the returns that Veru has given to Indian investors in the last 5 years?

Veru stock has given -87.13% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?